GenMark Diagnostics Shares Outstanding 2010-2018 | GNMK

Current and historical number of shares outstanding for GenMark Diagnostics (GNMK) from 2010 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
GenMark Diagnostics Annual Shares Outstanding
(Millions of US $)
2017 $51
2016 $44
2015 $42
2014 $41
2013 $35
2012 $26
2011 $17
2010 $10
2009 $5
GenMark Diagnostics Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $56
Q1 2018 $55
Q4 2017 $51
Q3 2017 $55
Q2 2017 $48
Q1 2017 $47
Q4 2016 $44
Q3 2016 $44
Q2 2016 $43
Q1 2016 $43
Q4 2015 $42
Q3 2015 $42
Q2 2015 $42
Q1 2015 $42
Q4 2014 $41
Q3 2014 $41
Q2 2014 $41
Q1 2014 $41
Q4 2013 $35
Q3 2013 $36
Q2 2013 $32
Q1 2013 $32
Q4 2012 $26
Q3 2012 $32
Q2 2012 $21
Q1 2012 $20
Q4 2011 $20
Q3 2011 $20
Q2 2011 $14
Q1 2011 $12
Q4 2010 $12
Q3 2010 $12
Q2 2010 $9
Q1 2010 $7
Q4 2009 $5
Q3 2009 $5
Q2 2009 $4
Q1 2009 $4
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.412B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $93.292B 22.38
Intuitive Surgical (ISRG) United States $60.172B 57.44
Fresenius Medical Care (FMS) Germany $29.566B 20.88
Edwards Lifesciences (EW) United States $28.713B 32.34
IDEXX Laboratories (IDXX) United States $21.074B 64.04
ABIOMED (ABMD) United States $16.661B 136.49
DexCom (DXCM) United States $11.259B 0.00
Hologic (HOLX) United States $10.686B 18.18
Teleflex (TFX) United States $10.580B 25.17
Varian Medical Systems (VAR) United States $10.133B 25.50
STERIS (STE) United Kingdom $9.685B 26.64
LivaNova (LIVN) United Kingdom $6.004B 35.81
Masimo (MASI) United States $5.810B 38.69
Integra LifeSciences Holdings (IART) United States $5.322B 27.54
Globus Medical (GMED) United States $5.155B 34.29
Inogen (INGN) United States $4.937B 130.64
Penumbra (PEN) United States $4.217B 383.28
Cantel Medical (CMD) United States $3.981B 41.50
Opko Health (OPK) United States $3.012B 0.00
Halyard Health (AVNS) United States $2.991B 24.61
Wright Medical Group (WMGI) Netherlands $2.954B 0.00
Integer Holdings (ITGR) United States $2.228B 20.17
Nevro (NVRO) United States $1.917B 0.00
Tandem Diabetes Care (TNDM) United States $1.782B 0.00
AxoGen (AXGN) United States $1.412B 0.00
Glaukos (GKOS) United States $1.412B 809.00
Natus Medical (BABY) United States $1.246B 26.42
Accelerate Diagnostics (AXDX) United States $1.242B 0.00
Mazor Robotics (MZOR) Israel $1.210B 0.00
Luminex (LMNX) United States $1.205B 35.55
CryoLife (CRY) United States $1.180B 103.55
Tactile Systems Technology (TCMD) United States $1.064B 181.38
TransEnterix (TRXC) United States $0.905B 0.00
K2Ms (KTWO) United States $0.876B 0.00
Intersect ENT (XENT) United States $0.824B 0.00
AngioDynamics (ANGO) United States $0.791B 29.38
Mesa Laboratories (MLAB) United States $0.785B 48.57
ViewRay (VRAY) United States $0.743B 0.00
Pacific Biosciences Of California (PACB) United States $0.598B 0.00
Sientra (SIEN) United States $0.596B 0.00
Neuronetics (STIM) United States $0.544B 0.00
Veracyte (VCYT) United States $0.416B 0.00
Quotient (QTNT) Switzerland $0.399B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.375B 0.00
OrthoPediatrics (KIDS) United States $0.366B 0.00
Accuray (ARAY) United States $0.310B 0.00
IRadimed (IRMD) United States $0.304B 109.61
RTI Surgical (RTIX) United States $0.295B 58.13
T2 Biosystems (TTOO) United States $0.290B 0.00
Fluidigm (FLDM) United States $0.280B 0.00
CRH Medical (CRHM) Canada $0.258B 32.27
Nuvectra (NVTR) United States $0.255B 0.00
Pulse Biosciences (PLSE) United States $0.246B 0.00
Helius Medical Technologies (HSDT) United States $0.227B 0.00
SeaSpine Holdings (SPNE) United States $0.203B 0.00
Ekso Bionics Holdings (EKSO) United States $0.176B 0.00
Corindus Vascular Robotics (CVRS) United States $0.171B 0.00
Apollo Endosurgery (APEN) United States $0.165B 0.00
Alphatec Holdings (ATEC) United States $0.138B 0.00
Second Sight Medical Products (EYES) United States $0.104B 0.00
Sensus Healthcare (SRTS) United States $0.096B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.096B 0.00
Viveve Medical (VIVE) United States $0.095B 0.00
EDAP TMS (EDAP) France $0.091B 0.00
Xtant Medical Holdings (XTNT) United States $0.082B 0.00
Invuity (IVTY) United States $0.081B 0.00
Neovasc (NVCN) Canada $0.066B 0.00
ConforMIS (CFMS) United States $0.059B 0.00
Restoration Robotics (HAIR) United States $0.050B 0.00
Electromed (ELMD) United States $0.043B 23.36
Vermillion (VRML) United States $0.039B 0.00
Presbia (LENS) Ireland $0.036B 0.00
OBALON THERPTCS (OBLN) United States $0.032B 0.00
Lianluo Smart (LLIT) China $0.029B 0.00
ReWalk Robotics (RWLK) Israel $0.028B 0.00
Microbot Medical (MBOT) United States $0.026B 0.00
DarioHealth (DRIO) Israel $0.025B 0.00
PAVmed (PAVM) United States $0.025B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.024B 0.00
Titan Medical (TMDI) Canada $0.024B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
Nanovibronix (NAOV) United States $0.019B 0.00
American Shared Hospital Services (AMS) United States $0.018B 14.09
Bioanalytical Systems (BASI) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Avinger (AVGR) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Amedica (AMDA) United States $0.002B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00